Niagen Bioscience Income Statement (2010-2025) | NAGE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	14.68M	17.70M	17.31M	17.76M	17.26M	16.73M	17.06M	21.00M	22.56M	20.32M	19.50M	21.20M	22.15M	22.74M	25.58M	29.12M	30.48M	31.12M	33.99M	33.84M
Cost of Revenue (Quarter)	6.26M	6.23M	6.73M	6.89M	6.73M	6.69M	5.87M	6.19M	7.87M	6.01M	6.04M	6.52M	6.74M	6.97M	7.04M	8.72M	2.48M	10.89M	12.06M	10.41M
Gross Profit (Quarter)	9.23M	10.81M	10.58M	10.87M	10.53M	10.04M	10.21M	12.02M	13.52M	12.36M	11.97M	12.94M	13.46M	13.69M	16.24M	18.20M	19.33M	20.23M	21.93M	21.70M
Operating items
Research & Development (Quarter)	0.79M	1.00M	1.00M	1.04M	1.08M	1.25M	1.22M	1.28M	1.19M	1.36M	1.24M	1.16M	2.10M	1.32M	1.29M	1.31M	1.26M	1.57M	1.79M	1.71M
Selling, General & Administrative (Quarter)	9.55M	9.13M	11.20M	6.50M	8.95M	7.16M	6.18M	5.99M	6.42M	7.30M	5.84M	5.43M	5.35M	5.66M	6.30M	1.05M	5.18M	7.27M	7.13M	7.48M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)	6.26M	6.23M	7.22M	8.64M	8.24M	8.02M	5.87M	6.19M	7.87M	6.01M	6.04M	6.52M	6.74M	6.97M	7.04M	8.72M	8.12M	8.21M	8.77M	8.43M
Operating Expenses (Quarter)	16.60M	16.36M	19.42M	16.18M	18.26M	16.43M	13.27M	13.46M	15.49M	14.67M	13.12M	13.11M	14.19M	13.95M	14.64M	11.09M	14.56M	17.04M	17.69M	17.62M
Operating Income (Quarter)	-7.36M	-5.55M	-8.84M	-5.32M	-7.73M	-6.39M	-3.06M	-1.44M	-1.97M	-2.32M	-1.15M	-0.17M	-0.73M	-0.26M	1.60M	7.11M	4.77M	3.19M	4.24M	4.09M
EBIT (Quarter)	-7.36M	-5.55M	-8.84M	-5.32M	-7.73M	-6.39M	-3.06M	-1.44M	-1.97M	-2.32M	-1.15M	-0.17M	-0.73M	-0.26M	1.60M	7.11M	4.77M	3.19M	4.24M	4.09M
Non-operating items
Interest & Investment Income (Quarter)										0.12M	0.19M	0.28M	0.24M	0.24M	0.28M	0.37M	0.46M	0.55M	0.56M	0.55M
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)
Net income details
EBT (Quarter)	-7.38M	-5.57M	-8.86M	-5.33M	-7.74M	-6.40M	-3.07M	-1.44M	-1.97M	-2.19M	-0.96M	0.11M	-0.49M	-0.01M	1.88M	7.48M	5.23M	3.74M	4.80M	4.42M
Tax Provisions (Quarter)																0.30M	0.17M	0.13M	0.22M	0.29M
Profit After Tax (Quarter)	-7.38M	-5.57M	-8.86M	-5.33M	-7.74M	-6.40M	-0.98M	-1.42M	-1.90M	-2.19M	-0.96M	0.11M	-0.49M	-0.01M	1.88M	7.18M	5.06M	3.61M	4.58M	4.13M
Income from Continuing Operations (Quarter)	-7.38M	-5.57M	-8.86M	-5.33M	-7.74M	-6.40M	-3.07M	-1.44M	-1.97M	-2.19M	-0.96M	0.11M	-0.49M	-0.01M	1.88M	7.18M	5.06M	3.61M	4.58M	4.13M
Consolidated Net Income (Quarter)	-7.38M	-5.57M	-8.86M	-5.33M	-7.74M	-6.40M	-3.07M	-1.44M	-1.97M	-2.19M	-0.96M	0.11M	-0.49M	-0.01M	1.88M	7.18M	5.06M	3.61M	4.58M	4.13M
Income towards Parent Company (Quarter)	-7.38M	-5.57M	-8.86M	-5.33M	-7.74M	-6.40M	-3.07M	-1.44M	-1.97M	-2.19M	-0.96M	0.11M	-0.49M	-0.01M	1.88M	7.18M	5.06M	3.61M	4.58M	4.13M
Net Income towards Common Stockholders (Quarter)	-7.38M	-5.57M	-8.86M	-5.33M	-7.74M	-6.40M	-3.07M	-1.44M	-1.97M	-2.19M	-0.96M	0.11M	-0.49M	-0.01M	1.88M	7.18M	5.06M	3.61M	4.58M	4.13M
Additional items
EPS (Basic) (Quarter)	-0.12	-0.08	-0.13	-0.07	-0.11	-0.09	-0.01	-0.02	-0.03	-0.03	-0.01	0.00	-0.01	0.00	0.02	0.09	0.07	0.05	0.06	0.05
EPS (Weighted Average and Diluted) (Quarter)	-0.12	-0.08	-0.13	-0.07	-0.11	-0.09	-0.01	-0.02	-0.03	-0.03	-0.01	0.00	-0.01	0.00	0.02	0.09	0.06	0.04	0.05	0.05
Shares Outstanding (Weighted Average) (Quarter)	64.16M	66.09M	68.24M	67.19M	68.31M	68.33M	68.34M	69.73M	74.80M	74.88M	75.05M	74.98M	75.23M	75.39M	75.59M	75.93M	77.81M	78.53M	78.95M	79.18M
Shares Outstanding (Diluted Average) (Quarter)	64.16M	67.99M	66.81M	67.19M	68.31M	68.33M	68.34M	69.73M	74.80M	74.97M	75.05M	74.98M	75.23M	75.39M	77.77M	78.12M	83.23M	84.88M	86.62M	85.44M
EBITDA (Quarter)	-7.36M	-5.55M	-8.84M	-5.32M	-7.73M	-6.39M	-3.06M	-1.44M	-1.97M	-2.32M	-1.15M	-0.17M	-0.73M	-0.26M	1.60M	7.11M	4.77M	3.19M	4.24M	4.09M
Interest Expenses (Quarter)	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Tax Rate (Quarter)																4.08%	3.21%	3.43%	4.63%	6.60%

Research Tools

Niagen Bioscience Income Statement (2010-2025) | NAGE

Create an account

Sign In

Reset Password